Browsing Tag
Dr. Frank Mathias
3 posts
Wilshire enhances investment suite with acquisition of Lyxor U.S.
Wilshire, a prominent global financial services firm, has successfully completed its acquisition of Lyxor Asset Management Inc. (“Lyxor…
Oxford Biomedica to acquire ABL Europe to expand global CDMO reach
Oxford Biomedica plc, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is set to…
Oxford Biomedica eyes ABL Europe acquisition to bolster cell and gene therapy CDMO operations
Oxford Biomedica plc and Institut Mérieux SA have entered exclusive negotiations concerning Oxford Biomedica’s proposed acquisition of ABL…